Medical Research
(H30Z)
IRS Verified
DX Registered
990 on File
NEUROFIBROMATOSIS INC
Financial strength (30%)
91/100
Reliability (20%)
84/100
Effectiveness (25%)
93/100
Impact (25%)
75/100
47
CharityAI™ Score
out of 100
Mission Statement
Is to find treatments and a cure for neurofibromatosis by promoting scientific research, improving clinical care, providing outreach through education and awareness, while offering hope and support to those affected by NF.
Financial Overview — FY 2024
N/A
Total Revenue
N/A
Total Expenses
N/A
Net Assets
5
Employees
Program Expense Ratio
N/A
Fundraising Efficiency
0.0%
Operating Reserve
N/A
Liability-to-Asset
0.0%
Revenue Diversification
N/A
Compared with Peers
FY 2024
Compared with 726 similar organizations
(United States, Medical Research, $100K–$1M in expenses), FY 2024.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Fundraising efficiency
Fundraising expenses / gross fundraising income
· lower is better
|
0.0% | 10.0% |
P10P90
|
Top quarter |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
0.0% | 0.4% |
P10P90
|
Top quarter |
|
Revenue growth
Year over year revenue growth
|
-100.0% | 9.1% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
-100.0% | 8.8% |
P10P90
|
CharityAI™ Evaluation — 2025
47 / 1000
Financial
84
Reliability
45
Effectiveness
75
Impact
Financial Strength (30%)
0
Reliability & Transparency (20%)
84
Program Effectiveness (25%)
45
Impact & Outcomes (25%)
75
2,400 served annually
$36 per beneficiary
2 programs
IRS Verified Form 990 on File 95% Data Complete
Impact
2 programs| Outcome / Program | People Served | Cost / Service | # Completed | Duration |
|---|---|---|---|---|
| neurofibromatosis patient education resources | 1,200 | $30.00 | — | Lifetime |
| neurofibromatosis medical specialist referral | 1,200 | $41.66 | — | Lifetime |
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2024 | N/A | N/A | N/A | — | 5 |
| 2023 | $410K | $488K | $1.2M | 84.9% | 5 |
| 2022 | $549K | $378K | $1.2M | 84.6% | 5 |
| 2021 | $683K | $316K | N/A | — | 3 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.